ATE191851T1 - TEICOPLANIN-CONTAINING, TOPICALLY APPLICABLE MEDICINAL PRODUCT WITH DELAYED RELEASE - Google Patents

TEICOPLANIN-CONTAINING, TOPICALLY APPLICABLE MEDICINAL PRODUCT WITH DELAYED RELEASE

Info

Publication number
ATE191851T1
ATE191851T1 AT94102332T AT94102332T ATE191851T1 AT E191851 T1 ATE191851 T1 AT E191851T1 AT 94102332 T AT94102332 T AT 94102332T AT 94102332 T AT94102332 T AT 94102332T AT E191851 T1 ATE191851 T1 AT E191851T1
Authority
AT
Austria
Prior art keywords
teicoplanin
delayed release
medicinal product
topically applicable
applicable medicinal
Prior art date
Application number
AT94102332T
Other languages
German (de)
Original Assignee
Melzer Wolfgang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melzer Wolfgang filed Critical Melzer Wolfgang
Application granted granted Critical
Publication of ATE191851T1 publication Critical patent/ATE191851T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Abstract

Delayed-release pharmaceutical composition which can be administered topically in the form of a dry product or of a suspension thereof in an inert liquid vehicle containing as sparingly water-soluble product the combination of A) teicoplanin with B) at least one other pharmaceutical agent with, as a rule, basic characteristics.
AT94102332T 1993-02-16 1994-02-16 TEICOPLANIN-CONTAINING, TOPICALLY APPLICABLE MEDICINAL PRODUCT WITH DELAYED RELEASE ATE191851T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4304716A DE4304716A1 (en) 1993-02-16 1993-02-16 Delayed-release topical drug

Publications (1)

Publication Number Publication Date
ATE191851T1 true ATE191851T1 (en) 2000-05-15

Family

ID=6480625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94102332T ATE191851T1 (en) 1993-02-16 1994-02-16 TEICOPLANIN-CONTAINING, TOPICALLY APPLICABLE MEDICINAL PRODUCT WITH DELAYED RELEASE

Country Status (3)

Country Link
EP (1) EP0611571B1 (en)
AT (1) ATE191851T1 (en)
DE (2) DE4304716A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022115A1 (en) * 1995-01-16 1996-07-25 Baxter International Inc. Self-supporting sheet-like material of cross-linked fibrin for preventing post operative adhesions
AU3720097A (en) 1996-07-12 1998-02-09 Baxter International Inc. A fibrin delivery device and method for forming fibrin on a surface
DE19856668A1 (en) * 1998-12-09 2000-06-15 Aesculap Ag & Co Kg Active substance matrix in the form of a bioabsorbable porous nonwoven, process for its preparation and use
DE10227935B4 (en) * 2002-06-21 2007-10-04 Heraeus Kulzer Gmbh Process for the preparation of an antibiotic coating of porous bodies and use
DE10227914A1 (en) 2002-06-21 2004-01-15 Heraeus Kulzer Gmbh & Co. Kg Pharmaceutical preparation with delayed release of active ingredient, process for its preparation and use
US7135027B2 (en) 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8802211D0 (en) * 1988-02-02 1988-03-02 Lepetit Spa Teicoplanin hydrazides
WO1991013595A1 (en) * 1990-03-15 1991-09-19 The United States Of America, As Represented By The Secretary Of The Army Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
AU647122B2 (en) * 1990-05-28 1994-03-17 Gruppo Lepetit S.P.A. C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy- teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics

Also Published As

Publication number Publication date
DE59409293D1 (en) 2000-05-25
EP0611571A1 (en) 1994-08-24
EP0611571B1 (en) 2000-04-19
DE4304716A1 (en) 1994-08-18

Similar Documents

Publication Publication Date Title
ATE148630T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING STABILIZED DERIVATIVES OF VITAMIN D2 AND D3
CA2163706A1 (en) Amino Acid Derivatives of Paclitaxel
AU8188987A (en) Improved metal complex-containing pharmaceutical agents
NO179911C (en) Optically active 5H-pyrrolo [3,4-bpyrazine derivative as well as pharmaceutical preparations containing the derivative
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
PL304649A1 (en) Novel derivatives of taxane and pharmaceutical agents
MX9200361A (en) NEW USE OF THE ADENOSINE ANTAGONIST.
MX9304710A (en) PHARMACEUTICAL AND / OR COSMETIC COMPOSITION AND ITS USE.
AU8188691A (en) The use of inositoltrisphosphate for the preparing of medicaments
DE69006654T2 (en) Medicines containing a zinc complex.
SE9604348D0 (en) Use of hydroxyguanidines
FR2691465B1 (en) COMPLEXES COMPRISING AT LEAST ONE ALPHA MSH-DERIVED PEPTIDE, PEPTIDE, MICROSPHERE, MEDICAMENT AND GALENIC COMPOSITION COMPRISING THE SAME.
ATE191851T1 (en) TEICOPLANIN-CONTAINING, TOPICALLY APPLICABLE MEDICINAL PRODUCT WITH DELAYED RELEASE
KR950007857A (en) Rapamycin preparations for oral administration
AU5459590A (en) Cleansing composition
CA2027814A1 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
NO923266D0 (en) Hexahydrobenzo (F) QUINOLINONER
DE69104608D1 (en) Pharmaceutical preparations containing clavulanic acid for the treatment of periodontitis.
DE59205998D1 (en) Medicament with antineoplastic activity containing octadecyl- [2- (N-methylpiperidino) ethyl] phosphate as active ingredient and process for its preparation
EP0597130A4 (en) Antirheumatic.
AU4132693A (en) Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component
EP0583606A3 (en) New hydrazono-5-beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same.
DK0626173T3 (en) Aerosol preparation containing fusafungin
ES2184121T3 (en) FORMULATION FOR THE TREATMENT AND / OR PROFILAXIS OF DEMENTIA.
FR2694292B1 (en) Benzimidazole-2-thione- derivatives, their preparation and their use as medicaments.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee